10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-23-028244 |
| Period End Date | 20230630 |
| Filing Date | 20230808 |
| Fiscal Year | 2023 |
| Fiscal Period | Q2 |
| XBRL Instance | dcgo-20230630_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
91 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accounts receivable, net of allowance (in Dollars) |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$7.82M | USD | Point-in-time |
| Accounts receivable, net of allowance (in Dollars) |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$4.20M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$157.34M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$109.16M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$198.14M | USD | Point-in-time |
| Accounts receivable, net of allowance of $4,204,532 and $7,818,702 as of June 30, 2023 and December 31, 2022, respectively |
ReceivablesNetCurrent
|
$118.50M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
500.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
500.00M | shares | Point-in-time |
| Accounts receivable, net of allowance of $4,204,532 and $7,818,702 as of June 30, 2023 and December 31, 2022, respectively |
ReceivablesNetCurrent
|
$103.00M | USD | Point-in-time |
| Assets held for sale |
AssetsOfDisposalGroupIncludingDiscontinuedOperation
|
- | USD | Point-in-time |
| Assets held for sale |
AssetsOfDisposalGroupIncludingDiscontinuedOperation
|
$4.48M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
102.41M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
103.76M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
102.41M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$6.27M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
103.76M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$6.79M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$234.45M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$271.08M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$21.26M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$21.94M | USD | Point-in-time |
| Intangibles, net |
IntangibleAssetsNetExcludingGoodwill
|
$38.05M | USD | Point-in-time |
| Intangibles, net |
IntangibleAssetsNetExcludingGoodwill
|
$22.97M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$47.82M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$38.90M | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$6.77M | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$14.60M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$9.07M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$9.29M | USD | Point-in-time |
| Finance lease right-of-use assets |
FinanceLeaseRightOfUseAsset
|
$8.96M | USD | Point-in-time |
| Finance lease right-of-use assets |
FinanceLeaseRightOfUseAsset
|
$9.04M | USD | Point-in-time |
| Equity method investment |
EquityMethodInvestments
|
$392.12K | USD | Point-in-time |
| Equity method investment |
EquityMethodInvestments
|
$597.98K | USD | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$11.25M | USD | Point-in-time |
| Deferred tax assets |
DeferredIncomeTaxAssetsNet
|
$9.96M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$3.63M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$3.54M | USD | Point-in-time |
| Total assets |
Assets
|
$331.86M | USD | Point-in-time |
| Total assets |
Assets
|
$393.28M | USD | Point-in-time |
| Total assets |
Assets
|
$390.29M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$21.58M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$6.69M | USD | Point-in-time |
| Accrued liabilities |
AccruedLiabilitiesCurrent
|
$31.57M | USD | Point-in-time |
| Accrued liabilities |
AccruedLiabilitiesCurrent
|
$34.79M | USD | Point-in-time |
| Notes payable, current |
LinesOfCreditCurrent
|
$696.31K | USD | Point-in-time |
| Notes payable, current |
LinesOfCreditCurrent
|
$664.91K | USD | Point-in-time |
| Due to seller |
NotesPayableCurrent
|
$17.90M | USD | Point-in-time |
| Due to seller |
NotesPayableCurrent
|
$26.24M | USD | Point-in-time |
| Contingent consideration |
BusinessCombinationContingentConsiderationLiability
|
$10.56M | USD | Point-in-time |
| Contingent consideration |
BusinessCombinationContingentConsiderationLiability
|
$26.49M | USD | Point-in-time |
| Operating lease liability, current |
OperatingLeaseLiabilityCurrent
|
$2.33M | USD | Point-in-time |
| Operating lease liability, current |
OperatingLeaseLiabilityCurrent
|
$2.48M | USD | Point-in-time |
| Liabilities held for sale |
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
- | USD | Point-in-time |
| Liabilities held for sale |
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
$4.48M | USD | Point-in-time |
| Finance lease liability, current |
FinanceLeaseLiabilityCurrent
|
$2.73M | USD | Point-in-time |
| Finance lease liability, current |
FinanceLeaseLiabilityCurrent
|
$2.72M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$91.76M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$100.16M | USD | Point-in-time |
| Notes payable, non-current |
LongTermNotesPayable
|
$1.24M | USD | Point-in-time |
| Notes payable, non-current |
LongTermNotesPayable
|
$1.58M | USD | Point-in-time |
| Operating lease liability, non-current |
OperatingLeaseLiabilityNoncurrent
|
$7.16M | USD | Point-in-time |
| Operating lease liability, non-current |
OperatingLeaseLiabilityNoncurrent
|
$7.04M | USD | Point-in-time |
| Finance lease liability, non-current |
FinanceLeaseLiabilityNoncurrent
|
$5.93M | USD | Point-in-time |
| Finance lease liability, non-current |
FinanceLeaseLiabilityNoncurrent
|
$5.91M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$114.35M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$106.43M | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock ($0.0001 par value; 500,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 103,762,092 and 102,411,162 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |
CommonStockValue
|
$10.24K | USD | Point-in-time |
| Common stock ($0.0001 par value; 500,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 103,762,092 and 102,411,162 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |
CommonStockValue
|
$10.38K | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapital
|
$301.45M | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapital
|
$312.10M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-33.73M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-28.97M | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$741.21K | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$1.39M | USD | Point-in-time |
| Total stockholders equity attributable to DocGo Inc. and Subsidiaries |
StockholdersEquity
|
$273.23M | USD | Point-in-time |
| Total stockholders equity attributable to DocGo Inc. and Subsidiaries |
StockholdersEquity
|
$279.77M | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$4.09M | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$5.70M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.86M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$240.26M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.92M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$227.06M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$278.93M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$254.39M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$390.29M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$393.28M | USD | Point-in-time |
Income Statement
113 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue, net |
Revenues
|
$227.41M | USD | 2 Qtrs |
| Revenue, net |
Revenues
|
$238.49M | USD | 2 Qtrs |
| Revenue, net |
Revenues
|
$125.49M | USD | 1 Quarter |
| Revenue, net |
Revenues
|
$109.52M | USD | 1 Quarter |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) |
CostOfRevenues
|
$148.16M | USD | 2 Qtrs |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) |
CostOfRevenues
|
$83.62M | USD | 1 Quarter |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) |
CostOfRevenues
|
$70.18M | USD | 1 Quarter |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) |
CostOfRevenues
|
$164.84M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$48.50M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$60.02M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$24.64M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$30.80M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$3.83M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$2.04M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortization
|
$4.24M | USD | 2 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortization
|
$7.48M | USD | 2 Qtrs |
| Legal and regulatory |
LegalFees
|
$4.41M | USD | 2 Qtrs |
| Legal and regulatory |
LegalFees
|
$3.06M | USD | 1 Quarter |
| Legal and regulatory |
LegalFees
|
$6.04M | USD | 2 Qtrs |
| Legal and regulatory |
LegalFees
|
$2.40M | USD | 1 Quarter |
| Technology and development |
ResearchAndDevelopmentExpense
|
$4.44M | USD | 2 Qtrs |
| Technology and development |
ResearchAndDevelopmentExpense
|
$1.15M | USD | 1 Quarter |
| Technology and development |
ResearchAndDevelopmentExpense
|
$2.29M | USD | 2 Qtrs |
| Technology and development |
ResearchAndDevelopmentExpense
|
$2.57M | USD | 1 Quarter |
| Sales, advertising and marketing |
SellingAndMarketingExpense
|
$2.26M | USD | 2 Qtrs |
| Sales, advertising and marketing |
SellingAndMarketingExpense
|
$992.63K | USD | 2 Qtrs |
| Sales, advertising and marketing |
SellingAndMarketingExpense
|
$685.39K | USD | 1 Quarter |
| Sales, advertising and marketing |
SellingAndMarketingExpense
|
$1.00M | USD | 1 Quarter |
| Total expenses |
OperatingExpenses
|
$102.06M | USD | 1 Quarter |
| Total expenses |
OperatingExpenses
|
$243.82M | USD | 2 Qtrs |
| Total expenses |
OperatingExpenses
|
$209.86M | USD | 2 Qtrs |
| Total expenses |
OperatingExpenses
|
$123.91M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$17.55M | USD | 2 Qtrs |
| Income (loss) from operations |
OperatingIncomeLoss
|
$7.46M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$1.58M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$-5.33M | USD | 2 Qtrs |
| Interest income (expense), net |
InterestIncomeExpenseNet
|
$1.33M | USD | 2 Qtrs |
| Interest income (expense), net |
InterestIncomeExpenseNet
|
$98.28K | USD | 1 Quarter |
| Interest income (expense), net |
InterestIncomeExpenseNet
|
$521.87K | USD | 1 Quarter |
| Interest income (expense), net |
InterestIncomeExpenseNet
|
$-37.33K | USD | 2 Qtrs |
| Gain on remeasurement of warrant liabilities |
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
$2.97M | USD | 2 Qtrs |
| Gain on remeasurement of warrant liabilities |
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
- | USD | 2 Qtrs |
| Gain on remeasurement of warrant liabilities |
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
- | USD | 1 Quarter |
| Gain on remeasurement of warrant liabilities |
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
$3.03M | USD | 1 Quarter |
| (Loss)/gain on initial equity method investments |
IncomeLossFromEquityMethodsInvestments
|
$-205.86K | USD | 2 Qtrs |
| (Loss)/gain on initial equity method investments |
IncomeLossFromEquityMethodsInvestments
|
$-90.57K | USD | 1 Quarter |
| (Loss)/gain on initial equity method investments |
IncomeLossFromEquityMethodsInvestments
|
$6.47K | USD | 2 Qtrs |
| (Loss)/gain on initial equity method investments |
IncomeLossFromEquityMethodsInvestments
|
$89.81K | USD | 1 Quarter |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
- | USD | 2 Qtrs |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.39M | USD | 1 Quarter |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.39M | USD | 2 Qtrs |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
- | USD | 1 Quarter |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.40M | USD | Point-in-time |
| Loss on disposal of fixed assets |
GainLossOnSaleOfPropertyPlantEquipment
|
- | USD | 1 Quarter |
| Loss on disposal of fixed assets |
GainLossOnSaleOfPropertyPlantEquipment
|
$-153.47K | USD | 2 Qtrs |
| Loss on disposal of fixed assets |
GainLossOnSaleOfPropertyPlantEquipment
|
$-98.63K | USD | 1 Quarter |
| Loss on disposal of fixed assets |
GainLossOnSaleOfPropertyPlantEquipment
|
- | USD | 2 Qtrs |
| Other (expense) income |
OtherNonoperatingIncomeExpense
|
$-920.06K | USD | 1 Quarter |
| Other (expense) income |
OtherNonoperatingIncomeExpense
|
$-705.18K | USD | 2 Qtrs |
| Other (expense) income |
OtherNonoperatingIncomeExpense
|
$15.64K | USD | 1 Quarter |
| Other (expense) income |
OtherNonoperatingIncomeExpense
|
$11.39K | USD | 2 Qtrs |
| Total other (expense) income |
OtherOperatingIncomeExpenseNet
|
$-587.39K | USD | 1 Quarter |
| Total other (expense) income |
OtherOperatingIncomeExpenseNet
|
$4.62M | USD | 1 Quarter |
| Total other (expense) income |
OtherOperatingIncomeExpenseNet
|
$4.34M | USD | 2 Qtrs |
| Total other (expense) income |
OtherOperatingIncomeExpenseNet
|
$266.54K | USD | 2 Qtrs |
| Net income (loss) before income tax benefit (expense) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$12.08M | USD | 1 Quarter |
| Net income (loss) before income tax benefit (expense) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$988.57K | USD | 1 Quarter |
| Net income (loss) before income tax benefit (expense) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$21.89M | USD | 2 Qtrs |
| Net income (loss) before income tax benefit (expense) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-5.06M | USD | 2 Qtrs |
| Income tax benefit (provision) |
IncomeTaxExpenseBenefit
|
$761.84K | USD | 2 Qtrs |
| Income tax benefit (provision) |
IncomeTaxExpenseBenefit
|
$-355.05K | USD | 1 Quarter |
| Income tax benefit (provision) |
IncomeTaxExpenseBenefit
|
$321.66K | USD | 1 Quarter |
| Income tax benefit (provision) |
IncomeTaxExpenseBenefit
|
$-2.48M | USD | 2 Qtrs |
| Net income (loss) |
ProfitLoss
|
$21.13M | USD | 2 Qtrs |
| Net income (loss) |
ProfitLoss
|
$-2.58M | USD | 2 Qtrs |
| Net income (loss) |
ProfitLoss
|
$11.76M | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$1.34M | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$3.35M | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-453.12K | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.24M | USD | 2 Qtrs |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$2.90M | USD | 2 Qtrs |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.26M | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-979.79K | USD | 1 Quarter |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$10.63M | USD | 1 Quarter |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-3.47M | USD | 1 Quarter |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-5.48M | USD | 2 Qtrs |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$23.37M | USD | 2 Qtrs |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$12.74M | USD | 1 Quarter |
| Net (loss) income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-2.01M | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$4.57K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$649.44K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$10.43K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$405.78K | USD | 1 Quarter |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTax
|
$23.37M | USD | 2 Qtrs |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTax
|
$12.75M | USD | 1 Quarter |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTax
|
$-1.61M | USD | 1 Quarter |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTax
|
$-4.83M | USD | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic (in dollars per share) |
EarningsPerShareBasic
|
$-0.05 | USD | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic (in dollars per share) |
EarningsPerShareBasic
|
$-0.02 | USD | 1 Quarter |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.23 | USD | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.13 | USD | 1 Quarter |
| Weighted-average shares outstanding - Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
103.59M | shares | 1 Quarter |
| Weighted-average shares outstanding - Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
100.37M | shares | 2 Qtrs |
| Weighted-average shares outstanding - Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
99.30M | shares | 1 Quarter |
| Weighted-average shares outstanding - Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
103.09M | shares | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.20 | USD | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$-0.05 | USD | 2 Qtrs |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$-0.02 | USD | 1 Quarter |
| Net (loss) income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.11 | USD | 1 Quarter |
| Weighted-average shares outstanding - Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
115.28M | shares | 1 Quarter |
| Weighted-average shares outstanding - Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
103.09M | shares | 2 Qtrs |
| Weighted-average shares outstanding - Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
103.59M | shares | 1 Quarter |
| Weighted-average shares outstanding - Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
116.35M | shares | 2 Qtrs |
Cash Flow Statement
107 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net (loss) income |
ProfitLoss
|
$21.13M | USD | 2 Qtrs |
| Net (loss) income |
ProfitLoss
|
$-2.58M | USD | 2 Qtrs |
| Net (loss) income |
ProfitLoss
|
$11.76M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$1.34M | USD | 1 Quarter |
| Depreciation of property and equipment |
DepreciationDepletionAndAmortization
|
$1.44M | USD | 2 Qtrs |
| Depreciation of property and equipment |
DepreciationDepletionAndAmortization
|
$3.07M | USD | 2 Qtrs |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$645.72K | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$1.28M | USD | 2 Qtrs |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$1.41M | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$2.78M | USD | 2 Qtrs |
| Amortization of finance lease right-of-use assets |
FinanceLeaseRightOfUseAssetAmortization
|
$1.63M | USD | 2 Qtrs |
| Amortization of finance lease right-of-use assets |
FinanceLeaseRightOfUseAssetAmortization
|
$1.52M | USD | 2 Qtrs |
| Loss on disposal of assets |
GainLossOnSaleOfOtherAssets
|
- | USD | 2 Qtrs |
| Loss on disposal of assets |
GainLossOnSaleOfOtherAssets
|
$-153.47K | USD | 2 Qtrs |
| Deferred tax asset |
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
- | USD | 2 Qtrs |
| Deferred tax asset |
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
$1.29M | USD | 2 Qtrs |
| Loss (gain) on equity method investment |
IncomeLossFromEquityMethodInvestments
|
$-205.86K | USD | 2 Qtrs |
| Loss (gain) on equity method investment |
IncomeLossFromEquityMethodInvestments
|
$30.29K | USD | 2 Qtrs |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$1.82M | USD | 2 Qtrs |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$976.69K | USD | 2 Qtrs |
| Stock based compensation |
ShareBasedCompensation
|
$11.80M | USD | 2 Qtrs |
| Stock based compensation |
ShareBasedCompensation
|
$3.50M | USD | 2 Qtrs |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
- | USD | 2 Qtrs |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.39M | USD | 1 Quarter |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.39M | USD | 2 Qtrs |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
- | USD | 1 Quarter |
| Gain on remeasurement of finance leases |
GainLossRemeasurementOfFinanceLeases
|
$1.40M | USD | Point-in-time |
| Loss on liquidation of business |
GainLossOnSaleOfBusiness
|
$70.28K | USD | 1 Quarter |
| Loss on liquidation of business |
GainLossOnSaleOfBusiness
|
- | USD | 2 Qtrs |
| Loss on liquidation of business |
GainLossOnSaleOfBusiness
|
$-70.28K | USD | 2 Qtrs |
| Gain on remeasurement of warrant liabilities |
FairValueAdjustmentOfWarrants
|
- | USD | 1 Quarter |
| Gain on remeasurement of warrant liabilities |
FairValueAdjustmentOfWarrants
|
- | USD | 2 Qtrs |
| Gain on remeasurement of warrant liabilities |
FairValueAdjustmentOfWarrants
|
$-3.03M | USD | 1 Quarter |
| Gain on remeasurement of warrant liabilities |
FairValueAdjustmentOfWarrants
|
$-2.97M | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$15.41M | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-4.31M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$3.17M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$223.47K | USD | 2 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$-2.13M | USD | 2 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$-86.33K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-2.93M | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-14.90M | USD | 2 Qtrs |
| Accrued liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$3.55M | USD | 2 Qtrs |
| Accrued liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$1.20M | USD | 2 Qtrs |
| Net cash (used in) provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$30.19M | USD | 2 Qtrs |
| Net cash (used in) provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-12.42M | USD | 2 Qtrs |
| Acquisition of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$3.56M | USD | 2 Qtrs |
| Acquisition of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$941.65K | USD | 2 Qtrs |
| Acquisition of intangibles |
PaymentsToAcquireIntangibleAssets
|
$1.93M | USD | 2 Qtrs |
| Acquisition of intangibles |
PaymentsToAcquireIntangibleAssets
|
$1.02M | USD | 2 Qtrs |
| Acquisition of businesses |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$20.20M | USD | 2 Qtrs |
| Acquisition of businesses |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | 2 Qtrs |
| Proceeds from disposal of property and equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$277.24K | USD | 2 Qtrs |
| Proceeds from disposal of property and equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
- | USD | 2 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.96M | USD | 2 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-25.42M | USD | 2 Qtrs |
| Proceeds from revolving credit line |
ProceedsFromLinesOfCredit
|
- | USD | 2 Qtrs |
| Proceeds from revolving credit line |
ProceedsFromLinesOfCredit
|
$1.00M | USD | 2 Qtrs |
| Repayments of notes payable |
RepaymentsOfNotesPayable
|
$288.00K | USD | 2 Qtrs |
| Repayments of notes payable |
RepaymentsOfNotesPayable
|
$247.71K | USD | 2 Qtrs |
| Due to seller |
PaymentsDueToSeller
|
$-2.56M | USD | 2 Qtrs |
| Due to seller |
PaymentsDueToSeller
|
$-877.09K | USD | 2 Qtrs |
| Noncontrolling interest contributions |
ProceedsFromMinorityShareholders
|
- | USD | 2 Qtrs |
| Noncontrolling interest contributions |
ProceedsFromMinorityShareholders
|
$2.06M | USD | 2 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.15M | USD | 2 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.12M | USD | 2 Qtrs |
| Common stock repurchased |
PaymentsForRepurchaseOfCommonStock
|
$497.90K | USD | 2 Qtrs |
| Common stock repurchased |
PaymentsForRepurchaseOfCommonStock
|
- | USD | 2 Qtrs |
| Equity costs |
PaymentsOfStockIssuanceCosts
|
$19.57K | USD | 2 Qtrs |
| Equity costs |
PaymentsOfStockIssuanceCosts
|
- | USD | 2 Qtrs |
| Payments on obligations under finance lease |
FinanceLeasePrincipalPayments
|
$766.49K | USD | 1 Quarter |
| Payments on obligations under finance lease |
FinanceLeasePrincipalPayments
|
$1.51M | USD | 2 Qtrs |
| Payments on obligations under finance lease |
FinanceLeasePrincipalPayments
|
$1.41M | USD | 2 Qtrs |
| Payments on obligations under finance lease |
FinanceLeasePrincipalPayments
|
$851.31K | USD | 1 Quarter |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.12M | USD | 2 Qtrs |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-3.19M | USD | 2 Qtrs |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.57K | USD | 2 Qtrs |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$685.08K | USD | 2 Qtrs |
| Net (decrease) increase in cash and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-40.35M | USD | 2 Qtrs |
| Net (decrease) increase in cash and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$29.36M | USD | 2 Qtrs |
| Cash and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$123.76M | USD | Point-in-time |
| Cash and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$164.11M | USD | Point-in-time |
| Cash and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$208.46M | USD | Point-in-time |
| Cash and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$179.11M | USD | Point-in-time |
| Cash and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$123.76M | USD | Point-in-time |
| Cash and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$164.11M | USD | Point-in-time |
| Cash and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$208.46M | USD | Point-in-time |
| Cash and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$179.11M | USD | Point-in-time |
| Cash paid for interest |
InterestPaidNet
|
$126.77K | USD | 2 Qtrs |
| Cash paid for interest |
InterestPaidNet
|
$129.36K | USD | 2 Qtrs |
| Cash paid for interest on finance lease liabilities |
CashPaidForInterestOnFinanceLeaseLiabilities
|
$222.65K | USD | 2 Qtrs |
| Cash paid for interest on finance lease liabilities |
CashPaidForInterestOnFinanceLeaseLiabilities
|
$259.05K | USD | 2 Qtrs |
| Cash paid for income taxes |
IncomeTaxesPaidNet
|
$761.84K | USD | 2 Qtrs |
| Cash paid for income taxes |
IncomeTaxesPaidNet
|
$4.22M | USD | 2 Qtrs |
| Right-of-use assets obtained in exchange for lease liabilities |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$2.19M | USD | 2 Qtrs |
| Right-of-use assets obtained in exchange for lease liabilities |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$1.54M | USD | 2 Qtrs |
| Fixed assets acquired in exchange for notes payable |
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
$623.02K | USD | 2 Qtrs |
| Fixed assets acquired in exchange for notes payable |
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
- | USD | 2 Qtrs |
| Cash |
CashAndCashEquivalentsAtCarryingValue
|
$157.34M | USD | Point-in-time |
| Cash |
CashAndCashEquivalentsAtCarryingValue
|
$109.16M | USD | Point-in-time |
| Cash |
CashAndCashEquivalentsAtCarryingValue
|
$198.14M | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$10.32M | USD | Point-in-time |
| Restricted cash |
RestrictedCash
|
$14.60M | USD | Point-in-time |
| Total cash and restricted cash shown in statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$123.76M | USD | Point-in-time |
| Total cash and restricted cash shown in statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$164.11M | USD | Point-in-time |
| Total cash and restricted cash shown in statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$208.46M | USD | Point-in-time |
| Total cash and restricted cash shown in statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$179.11M | USD | Point-in-time |
Stockholders Equity
44 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.86M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$240.26M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.92M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$227.06M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$278.93M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$254.39M | USD | Point-in-time |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$374.34K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$706.40K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$249.72K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$779.07K | USD | 1 Quarter |
| Stock based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.00M | USD | 1 Quarter |
| Stock based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$1.42M | USD | 1 Quarter |
| Common stock repurchased |
StockRepurchasedDuringPeriodValue
|
$497.90K | USD | 1 Quarter |
| Stock based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$1.78M | USD | 1 Quarter |
| Stock based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$8.18M | USD | 1 Quarter |
| UK Ltd. restricted stock (Note 4) |
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
$82.31K | USD | 1 Quarter |
| UK Ltd. restricted stock (Note 4) |
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
$167.18K | USD | 1 Quarter |
| Equity cost |
StockIssuedEffectOfReverseAcquisition
|
$-19.57K | USD | 1 Quarter |
| Noncontrolling interest contribution |
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
$2.06M | USD | 1 Quarter |
| Ambulnz Health liquidation |
GainLossOnSaleOfBusiness
|
$70.28K | USD | 1 Quarter |
| Ambulnz Health liquidation |
GainLossOnSaleOfBusiness
|
- | USD | 2 Qtrs |
| Ambulnz Health liquidation |
GainLossOnSaleOfBusiness
|
$-70.28K | USD | 2 Qtrs |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$3.35M | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-453.12K | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.24M | USD | 2 Qtrs |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$2.90M | USD | 2 Qtrs |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.26M | USD | 1 Quarter |
| Net income (loss) attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-979.79K | USD | 1 Quarter |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$10.43K | USD | 1 Quarter |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$243.66K | USD | 1 Quarter |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-5.86K | USD | 1 Quarter |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$405.78K | USD | 1 Quarter |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$10.63M | USD | 1 Quarter |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-3.47M | USD | 1 Quarter |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-5.48M | USD | 2 Qtrs |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$23.37M | USD | 2 Qtrs |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$12.74M | USD | 1 Quarter |
| Net income attributable to stockholders of DocGo Inc. and Subsidiaries |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-2.01M | USD | 1 Quarter |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.86M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$240.26M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$283.92M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$227.06M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$278.93M | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$254.39M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.